Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
766.42-
QQQ
728.070.92%
BTC/USD
85316.755.1222%
DIA
520.190.84%
GLD
399.290.47%
TLT
81.620.46%

Insight Molecular Diagnostics Inc (IMDX) Stock Price, Quote, News & History

IMDXNASDAQ
Trade with Public
Trade with Public
$4.00
0.051.27%
At close: Sep 17, 5:00 PM EST
$4.00
0.051.27%
Pre-Market: 7:00 AM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Insight Molecular (IMDX) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
-
Close
$4.00
Volume / Avg.
0 / 207.67K
Day Range
- - -
52 Wk Range
2.42 - 8.51
Market Cap
$130.90M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
47
Short Interest
5.72%
Days to Cover
8.81

Recent Insight Molecular Diagnostics Inc News

Alpha Buying: Insider Conviction in High-Risk Biotech

Tim Melvin

PRO
LUCID CAPITAL MARKETS Initiates Coverage On Insight Molecular with Buy Rating, Announces Price Target of $8

LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on Insight Molecular (NASDAQ:IMDX) with a Buy rating and announces Price Target of $8.
Benzinga Newsdesk

Transcript: Insight Molecular Q2 2026 Earnings Conference Call

Insight Molecular (NASDAQ:IMDX) released second-quarter financial results and hosted an earnings call on Monday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts
Benzinga Insights

PRO
Needham Reiterates Buy on Insight Molecular, Maintains $9 Price Target

Needham analyst Mike Matson reiterates Insight Molecular (NASDAQ:IMDX) with a Buy and maintains $9 price target.
Benzinga Newsdesk

PRO
Insight Molecular Diagnostics To Host Virtual KOL Event On August 17 To Discuss GraftAssure Platform Leveraging Digital PCR Technology For Reliable dd-cfDNA Results In Transplanted Organ Health Monitoring

Insight Molecular Diagnostics Inc., (NASDAQ:IMDX), (iMDx), today announced that it will host a virtual key opinion leader (KOL) event on Monday, August 17, 2026 at 11AM ET featuring Max Jacob Liebo, MD (Loyola
Benzinga Newsdesk

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-27.08M
Investing Cash Flow (TTM)
-3.92M
Financing Cash Flow (TTM)
23.76M
Free Cash Flow (TTM)
-31.00M
Capital Expenditure (TTM)
-3.92M
Net Change in Cash (TTM)
-7.24M

Analyst Trends and Forecast

2
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$116.75M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
81.71
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-37.72%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$0.65

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$595.00K
Total Cash
$17.76M
Debt to Equity
-
Issuance of Debt (TTM)
-$595.00K
Repayment of Debt (TTM)
-$595.00K

Key Statistics

Open
-
Close
$4.00
Volume / Avg.
0 / 207.67K
Day Range
- - -
52 Wk Range
2.42 - 8.51
Market Cap
$130.90M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
47
Short Interest
5.72%
Days to Cover
8.81

About

Sector
Health Care
Industry
Biotechnology
Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomar...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Insight Molecular (IMDX) stock?

A

You can purchase shares of Insight Molecular (NASDAQ:IMDX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Insight Molecular (IMDX) competitors?

Q

What is the forecast, or price target, for Insight Molecular (IMDX) stock?

A

Insight Molecular has a consensus price target of $9.67.

Q

What is the current price for Insight Molecular (IMDX)?

A

The stock price for Insight Molecular (NASDAQ: IMDX) is $4 last updated September 18, 2026 at 4:00 PM EDT.

Q

Does Insight Molecular (IMDX) pay a dividend?

A

There are no upcoming dividends for Insight Molecular.

Q

When is Insight Molecular (NASDAQ:IMDX) reporting earnings?

A

Insight Molecular does not have any upcoming earnings scheduled.

Q

Is Insight Molecular (IMDX) going to split?

A

There is no upcoming split for Insight Molecular.

Q

What sector and industry does Insight Molecular (IMDX) operate in?

A

Insight Molecular is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved